Alaunos Therapeutics Inc (TCRT) — Financial Flexibility Index
Alaunos Therapeutics Inc (TCRT) has a Financial Flexibility Index of -0.35x as of June 2026. Free cash flow of $-300.00K (operating CF $-300.00K minus capex $0.00) represents 0% of total liabilities ($864.00K). Check TCRT cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Alaunos Therapeutics Inc Financial Flexibility Index (2001–2025)
Historical Financial Flexibility Index trend for Alaunos Therapeutics Inc across 25 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Alaunos Therapeutics Inc.
Annual Financial Flexibility Index for Alaunos Therapeutics Inc (2001–2025)
Year-by-year free cash flow to debt coverage for Alaunos Therapeutics Inc. Explore TCRT operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.41x | $-2.77 Million | $-2.87 Million | $813.00K | ▲ +52.6% |
| 2024 | -7.18x | $-4.97 Million | $-4.97 Million | $692.00K | ▲ +53.1% |
| 2023 | -15.31x | $-29.95 Million | $-30.14 Million | $1.96 Million | ▼ -1292.0% |
| 2022 | -1.10x | $-29.02 Million | $-29.23 Million | $26.38 Million | ▲ +30.4% |
| 2021 | -1.58x | $-58.15 Million | $-61.47 Million | $36.81 Million | ▲ +25.2% |
| 2020 | -2.11x | $-47.23 Million | $-57.01 Million | $22.36 Million | ▲ +26.6% |
| 2019 | -2.88x | $-40.57 Million | $-40.85 Million | $14.10 Million | ▲ +44.3% |
| 2018 | -5.16x | $-49.00 Million | $-49.46 Million | $9.49 Million | ▼ -1838.4% |
| 2017 | -0.27x | $-53.93 Million | $-54.67 Million | $202.41 Million | ▲ +15.3% |
| 2016 | -0.31x | $-57.77 Million | $-58.33 Million | $183.65 Million | ▼ -5292.6% |
| 2015 | 0.01x | $402.00K | $-10.00K | $66.35 Million | ▲ +100.2% |
| 2014 | -3.20x | $-36.46 Million | $-36.65 Million | $11.40 Million | ▼ -20.5% |
| 2013 | -2.65x | $-59.38 Million | $-59.51 Million | $22.37 Million | ▼ -20.1% |
| 2012 | -2.21x | $-77.27 Million | $-78.83 Million | $34.96 Million | ▼ -114.1% |
| 2011 | -1.03x | $-37.68 Million | $-38.84 Million | $36.50 Million | ▼ -63.9% |
| 2010 | -0.63x | $-19.51 Million | $-19.69 Million | $30.97 Million | ▼ -10.9% |
| 2009 | -0.57x | $-12.28 Million | $-12.29 Million | $21.63 Million | ▲ +85.8% |
| 2008 | -4.01x | $-23.39 Million | $-23.52 Million | $5.83 Million | ▼ -21.9% |
| 2007 | -3.29x | $-20.91 Million | $-21.65 Million | $6.36 Million | ▲ +30.3% |
| 2006 | -4.72x | $-14.07 Million | $-14.42 Million | $2.98 Million | ▼ -25.0% |
| 2005 | -3.78x | $-8.65 Million | $-8.78 Million | $2.29 Million | ▼ -987.0% |
| 2004 | -0.35x | $-7.31K | $-7.31K | $21.05K | ▲ +4.2% |
| 2003 | -0.36x | $-9.33K | $-9.33K | $25.72K | ▲ +43.5% |
| 2002 | -0.64x | $-11.45K | $-11.77K | $17.84K | ▲ +88.3% |
| 2001 | -5.50x | $-30.26K | $-30.26K | $5.50K | — |